Are KW, BRNS, AFBI Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLP is investigating potential violations of federal securities laws and breaches of fiduciary duties to shareholders concerning several companies. The investigation centers on possible financial benefits to insiders that may not be available to ordinary shareholders.

One company under scrutiny is Kennedy-Wilson Holdings, Inc. (NYSE: KW), which is involved in a sale to a consortium led by William McMorrow, the company’s Chairman and CEO, and several other senior executives. The transaction is priced at $10.90 per share in cash.

Additionally, Barinthus Biotherapeutics plc (NASDAQ: BRNS) is in the spotlight due to its merger with Clywedog Therapeutics, Inc. Under this agreement, shareholders of Barinthus will receive one share of common stock in the newly combined entity for each American Depositary Share or ordinary share owned.

The investigation also extends to Affinity Bancshares, Inc. (NASDAQ: AFBI), which is being sold to Fidelity BancShares (N.C.), Inc. for $23.00 per share in cash. This price is subject to adjustment based on Affinity's adjusted stockholders' equity at closing.

Halper Sadeh LLP is encouraging shareholders of these companies to contact the firm to discuss their rights and options at no cost. The firm operates on a contingent fee basis, meaning clients are not responsible for upfront legal fees or expenses.

The firm represents investors globally who have experienced securities fraud and corporate misconduct, striving for corporate reforms and recovery of damages for affected investors.